FRBCX
Price
$31.95
Change
+$0.08 (+0.25%)
Updated
Sep 11 closing price
Net Assets
952.32M
SBFAX
Price
$27.72
Change
+$0.13 (+0.47%)
Updated
Sep 11 closing price
Net Assets
95.58M
Interact to see
Advertisement

FRBCX vs SBFAX

FRBCX vs SBFAX Comparison Chart in %
View a ticker or compare two or three
VS
FRBCX vs. SBFAX commentary
Sep 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FRBCX is a StrongBuy and SBFAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FRBCX has more cash in the bank: 952M vs. SBFAX (95.6M). FRBCX pays higher dividends than SBFAX: FRBCX (0.79) vs SBFAX (0.07). FRBCX was incepted earlier than SBFAX: FRBCX (28 years) vs SBFAX (28 years). FRBCX (1.96) is less costly to investors than SBFAX (1.46). SBFAX is a more actively managed with annual turnover of: 9.00 vs. FRBCX (5.00). FRBCX (1000) and SBFAX (1000) have matching initial minimum investment requirements. FRBCX annual gain was more profitable for investors over the last year : 12.09 vs. SBFAX (-9.74). FRBCX return over 5 years is better than : 15.99 vs. SBFAX (-12.92).
FRBCXSBFAXFRBCX / SBFAX
Total Expense Ratio1.951.46134%
Annual Report Gross Expense Ratio1.961.46134%
Fund Existence28 years28 years-
Gain YTD17.6754.349406%
Front LoadN/A6%-
Min. Initial Investment10001000100%
Min. Initial Investment IRAN/AN/A-
Net Assets952M95.6M996%
Annual Yield % from dividends0.790.071,183%
Returns for 1 year12.09-9.74-124%
Returns for 3 years63.609.91642%
Returns for 5 years15.99-12.92-124%
Returns for 10 years77.0843.44177%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
WDIAX17.04N/A
N/A
Wilmington Enhanced Div Inc Strat A
SGGCX55.12N/A
N/A
DWS Large Cap Focus Growth C
GCMAX39.07N/A
N/A
Goldman Sachs Mid Cap Value A
MINJX49.27N/A
N/A
MFS International Intrinsic Equity R6
FIKCX74.56N/A
N/A
Fidelity Advisor Health Care Z